Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Salient Surgical Technologies has launched the Aquamantys epidural vein sealer bipolar device, as part of its ongoing effort to improve patient outcomes for spinal procedures and reduce non-routine patient discharges for its hospital customers.
Subscribe to our email newsletter
According to Salient Surgical, the epidural vein sealer (EVS) is designed to address the challenging anatomy in minimally invasive spine surgery and is the latest product introduction on the company’s proprietary Aquamantys platform.
The EVS employs Transcollation advanced energy technology to significantly reduce bleeding in hard-to-reach areas. Reducing blood loss improves visualization for the surgeon, can result in improved clinical outcomes for the patient and may result in lower costs to the hospital, the company said.
Transcollation technology is a calibrated fusion of radiofrequency energy and saline that seals bleeding tissues, vessels and bone at the surgical site. The innovation of the EVS is the ability to deliver Transcollation technology through miniaturized electrodes, which provide direct and precise compression of epidural veins around critical structures, the company added.
Joe Army, CEO of Salient Surgical Technologies, said: “The EVS represents the latest in a series of innovations designed to improve patient outcomes and reduce hospital costs that we have planned for 2009.”